(Q44694720)

5 December 2017

title

Cholecalciferol administration blunts the systemic renin-angiotensin system in essential hypertensives with hypovitaminosis D. (English)

1 reference

5 December 2017

1 reference

7

1 reference

5 December 2017

Davide Carrara

1

1 reference

5 December 2017

Matteo Bernini

2

1 reference

5 December 2017

Alessandra Bacca

3

1 reference

5 December 2017

Ilaria Rugani

4

1 reference

5 December 2017

Emiliano Duranti

5

1 reference

5 December 2017

Agostino Virdis

6

1 reference

5 December 2017

Stefano Taddei

8

1 reference

5 December 2017

Giampaolo Bernini

9

1 reference

5 December 2017

publication date

2 January 2013

1 reference

Journal of the Renin-Angiotensin-Aldosterone System

5 December 2017

published in

1 reference

5 December 2017

volume

15

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

82-87

1 reference

Vitamin D and Hypertension: Current Evidence and Future Directions

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1470320312471149

Vitamin D deficiency and risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320312471149

Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320312471149

Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320312471149

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320312471149

Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320312471149

Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320312471149

1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320312471149

Suppression of renin-angiotensin gene expression in the kidney by paricalcitol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320312471149

1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320312471149

1,25-dihydroxyvitamin D3 reduces systolic blood pressure in hypertensive adults: a pilot feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320312471149

Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320312471149

The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320312471149

Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320312471149

Urinary angiotensinogen is correlated with blood pressure in men (Bogalusa Heart Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320312471149

Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320312471149

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320312471149

Quantification of human angiotensinogen by a novel sandwich ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320312471149

25-Hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320312471149

Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320312471149

Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320312471149

Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1470320312471149

21 January 2018

Identifiers

DOI

10.1177/1470320312471149

1 reference

5 December 2017

1 reference